Ginkgo BioWorks raises $45M in monster Series B venture round
In Massachusetts, Ginkgo Bioworks has raised $45 million in an oversubscribed Series B round. Viking Global, a firm managing more than $30 billion in capital, led the round along with previous investors including OS Fund, Y Combinator and Felicis Ventures. The new funds will be used to expand into new categories such as pharmaceuticals, cosmetics and probiotics, as […]









